Gastroenterology clinical trials recruiting in Texas

94 recruiting gastroenterology trials match in Texas. Showing 20.

• Quantifying Hepatic Mitochondrial Fluxes in HumansRecruiting

  Phase 4 · The University of Texas Health Science Center at San Antonio · San Antonio, Texas

• A Study of Efimosfermin Alfa in Adults With Hepatic ImpairmentRecruiting

  Phase 1 · GlaxoSmithKline · San Antonio, Texas

• A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Janssen Research & Development, LLC · Fort Worth, Texas

• Standardized Microbiota Transplant Therapy in Crohn's DiseaseRecruiting

  Phase 2 · University of Minnesota · Dallas, Texas

• Study of the Kono-S Anastomosis Versus the Side-to-side Functional End AnastomosisRecruiting

  N/A · Weill Medical College of Cornell University · New York, New York

• Non-Invasive Quantification of Liver Health in NASH (N-QUAN)Recruiting

  N/A · Perspectum · Chandler, Arizona

• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 / Phase 3 · Janssen Research & Development, LLC · Austin, Texas

• A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)Recruiting

  Phase 2 · GlaxoSmithKline · Corsicana, Texas

• A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)Recruiting

  Phase 2 · Takeda · Tyler, Texas

• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)Recruiting

  Phase 3 · Takeda · Phoenix, Arizona

• A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)Recruiting

  Phase 2 · Rivus Pharmaceuticals, Inc. · Austin, Texas

• Abbott Cephea Mitral Valve Disease RegistryRecruiting

  N/A · Abbott Medical Devices · Houston, Texas

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 · Abivax S.A. · Bellaire, Texas

• A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's DiseaseRecruiting

  Phase 2 · Eli Lilly and Company · Kingwood, Texas

• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:Recruiting

  Phase 2 · Eli Lilly and Company · Cedar Park, Texas

• Truncal Vagotomy in Patients Undergoing Revisional Sleeve Gastrectomy to Gastric BypassRecruiting

  N/A · Baylor Research Institute · Dallas, Texas

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Recruiting

  Phase 3 · Eli Lilly and Company · Austin, Texas

• A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)Recruiting

  Phase 3 · GlaxoSmithKline · Arlington, Texas

• A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Sanofi · Lubbock, Texas

• A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)Recruiting

  Phase 2 · Boehringer Ingelheim · Arlington, Texas

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.